anti-CD20 antibody

December 21, 2018

Bio-Thera Begins Phase 1 Trial of BAT4306F in Advanced B-cell Non-Hodgkin’s Lymphoma

News

Bio-Thera Solutions has started dosing patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma with its investigational therapy BAT4306F in a Phase 1 clinical trial. Taking place in China, the trial (ChiCTR1800018900) ... Read more

August 8, 2018

Gazyva-Revlimid Combo Shows Promise for Follicular Lymphoma Patients in Clinical Trial

News

Gazyva (obinutuzumab) with Revlimid (lenalidomide) — a combination called Galen — is a potentially safe and effective treatment for relapsed or refractory follicular lymphoma, with over 60% of patients responding to treatment, ... Read more